At a Glance
CTI Life Sciences Fund is a venture capital firm founded in 2006. CTI Life Sciences Fund is a leading Canadian biotech venture capital firm with a global footprint. The firm focuses on Pre-Seed, Seed, Series A, Series B+ investments across sectors including Aerospace & Defense, Digital Health, Other, Consumer, Fintech.
“Invests in early-stage life sciences and biotechnology companies developing innovative therapeutics and medical technologies.”
CTI Life Sciences Fund primarily invests at the Pre-Seed, Seed, Series A, Series B+ stages. This means they focus on companies that are at the earliest idea or prototype phase.
CTI Life Sciences Fund focuses on investments in Aerospace & Defense, Digital Health, Other, Consumer, Fintech. Their portfolio reflects deep expertise and networks within these sectors.
CTI Life Sciences Fund's typical investment check size ranges from $. to $.. Actual amounts may vary based on the stage, sector, and specific opportunity.
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.